Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
27
IVF Quote, Financials, Valuation and Earnings
Last price:
$0.82
Seasonality move
:
10.27%
Day range:
$0.77 - $0.84
52-week range:
$0.74 - $17.04
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.08x
P/B ratio:
--
Volume:
581.9K
Avg. volume:
440K
1-year change:
-91.36%
Market cap:
$1.8M
Revenue:
$6.5M
EPS (TTM):
-$34.05
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1M | $4.2M | $822.2K | $3M | $6.5M | |
| Revenue Growth (YoY) | -29.92% | 301.06% | -80.24% | 267.38% | 116.25% | |
| Cost of Revenues | $88.8K | $145.1K | $850.8K | $1.9M | $3.7M | |
| Gross Profit | $948.5K | $4M | -$28.6K | $1.1M | $2.9M | |
| Gross Profit Margin | 91.44% | 96.51% | -3.48% | 35.96% | 44% | |
| R&D Expenses | $398.4K | $216.4K | $544K | $166K | $489.7K | |
| Selling, General & Admin | $6.1M | $9M | $10M | $7.5M | $9.1M | |
| Other Inc / (Exp) | -- | -$172K | -$204K | -$313.8K | -$448.6K | |
| Operating Expenses | $6.5M | $9.2M | $10.6M | $7.9M | $10.5M | |
| Operating Income | -$5.5M | -$5.2M | -$10.6M | -$6.8M | -$7.6M | |
| Net Interest Expenses | $2.8M | $1.3M | $59.1K | $925.9K | $1.1M | |
| EBT. Incl. Unusual Items | -$8.3M | -$6.7M | -$10.9M | -$8M | -$9.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $40 | $4.8K | $2.9K | $27.8K | -$22.9K | |
| Net Income to Company | -$8.3M | -$6.7M | -$10.9M | -$8M | -$9.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$8.3M | -$6.7M | -$10.9M | -$8M | -$9.1M | |
| Basic EPS (Cont. Ops) | -$364.80 | -$151.20 | -$215.64 | -$67.37 | -$30.19 | |
| Diluted EPS (Cont. Ops) | -$364.80 | -$151.20 | -$215.64 | -$67.37 | -$30.19 | |
| Weighted Average Basic Share | $22.9K | $44.3K | $50.5K | $119.3K | $309.5K | |
| Weighted Average Diluted Share | $22.9K | $44.3K | $50.5K | $119.3K | $309.5K | |
| EBITDA | -$5.5M | -$5.2M | -$10.8M | -$6.9M | -$7.1M | |
| EBIT | -$5.5M | -$5.4M | -$10.8M | -$7.1M | -$8.1M | |
| Revenue (Reported) | $1M | $4.2M | $822.2K | $3M | $6.5M | |
| Operating Income (Reported) | -$5.5M | -$5.2M | -$10.6M | -$6.8M | -$7.6M | |
| Operating Income (Adjusted) | -$5.5M | -$5.4M | -$10.8M | -$7.1M | -$8.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $684.5K | $162.6K | $348K | $1.6M | $1.6M | |
| Revenue Growth (YoY) | 164.73% | -76.25% | 114.04% | 352.92% | 3.86% | |
| Cost of Revenues | $62.8K | $65K | $231K | $850.2K | $1M | |
| Gross Profit | $621.8K | $97.6K | $117K | $726.1K | $592.3K | |
| Gross Profit Margin | 90.83% | 60.05% | 33.62% | 46.06% | 36.18% | |
| R&D Expenses | $66.3K | $104.2K | $73.5K | $4.9K | $265.7K | |
| Selling, General & Admin | $2.1M | $2.7M | $2.3M | $1.4M | $2.6M | |
| Other Inc / (Exp) | -$460 | -$72.1K | -$27.9K | -$467K | -$14.6M | |
| Operating Expenses | $2.2M | $2.8M | $2.4M | $1.7M | $3.1M | |
| Operating Income | -$1.6M | -$2.7M | -$2.3M | -$946.4K | -$2.5M | |
| Net Interest Expenses | $893.2K | $1.2K | $216.6K | $181.3K | $311.3K | |
| EBT. Incl. Unusual Items | -$2.5M | -$2.8M | -$2.6M | -$1.6M | -$17.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $1.8K | -- | |
| Net Income to Company | -$2.5M | -$2.8M | -$2.6M | -$1.6M | -$17.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$2.5M | -$2.8M | -$2.6M | -$1.6M | -$17.4M | |
| Basic EPS (Cont. Ops) | -$60.00 | -$55.20 | -$49.20 | -$7.55 | -$12.53 | |
| Diluted EPS (Cont. Ops) | -$60.00 | -$55.20 | -$49.20 | -$7.55 | -$12.53 | |
| Weighted Average Basic Share | $41.2K | $50.2K | $51.9K | $211.3K | $1.4M | |
| Weighted Average Diluted Share | $41.2K | $50.2K | $51.9K | $211.3K | $1.4M | |
| EBITDA | -$1.5M | -$2.7M | -$2.3M | -$1.2M | -$16.9M | |
| EBIT | -$1.6M | -$2.8M | -$2.3M | -$1.4M | -$17.1M | |
| Revenue (Reported) | $684.5K | $162.6K | $348K | $1.6M | $1.6M | |
| Operating Income (Reported) | -$1.6M | -$2.7M | -$2.3M | -$946.4K | -$2.5M | |
| Operating Income (Adjusted) | -$1.6M | -$2.8M | -$2.3M | -$1.4M | -$17.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5M | $3.6M | $1M | $4.2M | $6.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $121.5K | $147.3K | $907.2K | $2.6M | $3.9M | |
| Gross Profit | $1.3M | $3.5M | $100.4K | $1.7M | $2.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $434.6K | $254.3K | $513.4K | $97.3K | $750.4K | |
| Selling, General & Admin | $6.6M | $9.6M | $9.8M | $6.6M | $10.2M | |
| Other Inc / (Exp) | -$500 | -$243.6K | -$159.7K | -$752.9K | -$14.6M | |
| Operating Expenses | $7M | $9.8M | $10.3M | $7.1M | $11.9M | |
| Operating Income | -$5.7M | -$6.4M | -$10.2M | -$5.4M | -$9.1M | |
| Net Interest Expenses | $3.7M | $369.7K | $274.5K | $890.6K | $1.2M | |
| EBT. Incl. Unusual Items | -$9.4M | -$7M | -$10.7M | -$7.1M | -$24.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $2.9K | $29.6K | -$24.7K | |
| Net Income to Company | -$9.4M | -$7M | -$10.7M | -$7.1M | -$24.9M | |
| Minority Interest in Earnings | -- | $238.5K | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$9.4M | -$7M | -$10.7M | -$7.1M | -$24.9M | |
| Basic EPS (Cont. Ops) | -$304.96 | -$146.40 | -$209.52 | -$62.27 | -$34.05 | |
| Diluted EPS (Cont. Ops) | -$304.96 | -$146.40 | -$209.52 | -$62.27 | -$34.05 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$5.6M | -$6.4M | -$10.3M | -$5.8M | -$22.8M | |
| EBIT | -$5.7M | -$6.6M | -$10.4M | -$6.2M | -$23.7M | |
| Revenue (Reported) | $1.5M | $3.6M | $1M | $4.2M | $6.6M | |
| Operating Income (Reported) | -$5.7M | -$6.4M | -$10.2M | -$5.4M | -$9.1M | |
| Operating Income (Adjusted) | -$5.7M | -$6.6M | -$10.4M | -$6.2M | -$23.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $684.5K | $162.6K | $348K | $1.6M | $1.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $62.8K | $65K | $231K | $850.2K | $1M | |
| Gross Profit | $621.8K | $97.6K | $117K | $726.1K | $592.3K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $66.3K | $104.2K | $73.5K | $4.9K | $265.7K | |
| Selling, General & Admin | $2.1M | $2.7M | $2.3M | $1.4M | $2.6M | |
| Other Inc / (Exp) | -$460 | -$72.1K | -$27.9K | -$467K | -$14.6M | |
| Operating Expenses | $2.2M | $2.8M | $2.4M | $1.7M | $3.1M | |
| Operating Income | -$1.6M | -$2.7M | -$2.3M | -$946.4K | -$2.5M | |
| Net Interest Expenses | $893.2K | $1.2K | $216.6K | $181.3K | $311.3K | |
| EBT. Incl. Unusual Items | -$2.5M | -$2.8M | -$2.6M | -$1.6M | -$17.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $1.8K | -- | |
| Net Income to Company | -$2.5M | -$2.8M | -$2.6M | -$1.6M | -$17.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$2.5M | -$2.8M | -$2.6M | -$1.6M | -$17.4M | |
| Basic EPS (Cont. Ops) | -$60.00 | -$55.20 | -$49.20 | -$7.55 | -$12.53 | |
| Diluted EPS (Cont. Ops) | -$60.00 | -$55.20 | -$49.20 | -$7.55 | -$12.53 | |
| Weighted Average Basic Share | $41.2K | $50.2K | $51.9K | $211.3K | $1.4M | |
| Weighted Average Diluted Share | $41.2K | $50.2K | $51.9K | $211.3K | $1.4M | |
| EBITDA | -$1.5M | -$2.7M | -$2.3M | -$1.2M | -$16.9M | |
| EBIT | -$1.6M | -$2.8M | -$2.3M | -$1.4M | -$17.1M | |
| Revenue (Reported) | $684.5K | $162.6K | $348K | $1.6M | $1.6M | |
| Operating Income (Reported) | -$1.6M | -$2.7M | -$2.3M | -$946.4K | -$2.5M | |
| Operating Income (Adjusted) | -$1.6M | -$2.8M | -$2.3M | -$1.4M | -$17.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $10.1M | $5.7M | $90.1K | $232.4K | $741.4K | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $21.7K | $50.5K | $77.2K | $140.6K | $174.9K | |
| Inventory | $265.4K | $287.8K | $263.6K | $264.5K | $219.8K | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $157.7K | $282.8K | $190.2K | $622.3K | $182.3K | |
| Total Current Assets | $10.5M | $6.3M | $621.1K | $1.3M | $1.3M | |
| Property Plant And Equipment | $211.5K | $2.5M | $1.9M | $4.2M | $2.8M | |
| Long-Term Investments | $98.1K | $1.5M | $1.2M | $3.1M | $740.8K | |
| Goodwill | -- | -- | -- | $5.9M | $23.5M | |
| Other Intangibles | $95K | $132.1K | -- | $4.1M | $18.1M | |
| Other Long-Term Assets | $240 | -- | -- | -- | -- | |
| Total Assets | $10.9M | $10.5M | $3.7M | $18.5M | $46.4M | |
| Accounts Payable | $328.9K | $443.4K | $1.3M | $2.3M | $5.7M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $536.1K | -- | $100K | $629.9K | $5.5M | |
| Current Portion Of Capital Lease Obligations | $22.7K | $222K | $160.2K | $181.6K | $239.1K | |
| Other Current Liabilities | -- | -- | -- | $350K | $410K | |
| Total Current Liabilities | $2.3M | $1.3M | $3.3M | $8M | $17.9M | |
| Long-Term Debt | -- | -- | -- | $1.3M | $1.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.2M | $3.2M | $4.7M | $17.6M | $33.7M | |
| Common Stock | $960 | $1.2K | $60 | $6M | $30.4M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $5.7M | $7.3M | -$977.6K | -$5.1M | -$17.6M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $5.7M | $7.3M | -$977.6K | $892.6K | $12.7M | |
| Total Liabilities and Equity | $10.9M | $10.5M | $3.7M | $18.5M | $46.4M | |
| Cash and Short Terms | $10.1M | $5.7M | $90.1K | $232.4K | $741.4K | |
| Total Debt | $693.7K | -- | $762.6K | $2.8M | $7.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.4M | $3.8M | $2.2M | $475.1K | $840.4K | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $527.7K | $58.7K | $99.7K | $176.9K | $173.6K | |
| Inventory | $268.4K | $294.6K | $270.9K | $266.5K | $216.5K | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $364K | $228.2K | $250.9K | $806.5K | $338.6K | |
| Total Current Assets | $9.6M | $4.4M | $2.8M | $1.7M | $1.6M | |
| Property Plant And Equipment | $203.3K | $2.5M | $2.2M | $3.8M | $2.7M | |
| Long-Term Investments | -- | $1.5M | $1.2M | $3M | $710.9K | |
| Goodwill | -- | -- | -- | $5.9M | $8.9M | |
| Other Intangibles | $123.5K | $132.6K | -- | $3.9M | $17.9M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $10.2M | $8.5M | $6.2M | $18.3M | $31.7M | |
| Accounts Payable | $512K | $462.2K | $1.8M | $2.8M | $4.8M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $185.5K | -- | -- | $795.8K | $4.5M | |
| Current Portion Of Capital Lease Obligations | $23.1K | $224.4K | $234.1K | $352.6K | $247.8K | |
| Other Current Liabilities | -- | -- | -- | $350K | $715.3K | |
| Total Current Liabilities | $1.9M | $1.1M | $4.5M | $9M | $18.7M | |
| Long-Term Debt | -- | -- | -- | $1.2M | $1.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.6M | $2.9M | $6.1M | $18.3M | $28.4M | |
| Common Stock | $1K | $1.2K | $1.4K | $6.5M | $30.4M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | $500K | -$4M | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $5.6M | $5.6M | $88.5K | $10.2K | $3.3M | |
| Total Liabilities and Equity | $10.2M | $8.5M | $6.2M | $18.3M | $31.7M | |
| Cash and Short Terms | $8.4M | $3.8M | $2.2M | $475.1K | $840.4K | |
| Total Debt | $343.1K | -- | $1.1M | $2.9M | $6.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$8.3M | -$6.7M | -$10.9M | -$8M | -$9.1M | |
| Depreciation & Amoritzation | $34.5K | $166.1K | $77.3K | $200.9K | $919.6K | |
| Stock-Based Compensation | $1.8M | $2.7M | $2.2M | $1.4M | $1.6M | |
| Change in Accounts Receivable | -$14.1K | -$28.8K | -$26.7K | -$63.4K | -$34.3K | |
| Change in Inventories | -$164K | -$22.4K | $24.2K | -$910 | $44.7K | |
| Cash From Operations | -$4.8M | -$6M | -$6.6M | -$4.8M | -$3M | |
| Capital Expenditures | $88.9K | $454.6K | $12.7K | $444.7K | $183.7K | |
| Cash Acquisitions | -$98.1K | -$1.7M | -$68.5K | -$2.1M | $472K | |
| Cash From Investing | -$187.3K | -$2.2M | -$81.2K | -$2.5M | $363.9K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.2M | -- | $800K | $3.2M | $1.3M | |
| Long-Term Debt Repaid | -$810K | -$250K | -- | -$1.5M | -$934.4K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $13.8M | $3.8M | $1.1M | $7.4M | $3.1M | |
| Beginning Cash (CF) | $1.2M | $10.1M | $5.7M | $90.1K | $232.4K | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $8.9M | -$4.4M | -$5.6M | $142.3K | $509K | |
| Ending Cash (CF) | $10.1M | $5.7M | $90.1K | $232.4K | $741.4K | |
| Levered Free Cash Flow | -$4.9M | -$6.5M | -$6.6M | -$5.2M | -$3.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$2.5M | -$2.8M | -$2.6M | -$1.6M | -$17.4M | |
| Depreciation & Amoritzation | $8.7K | $72.5K | $19.1K | $227K | $234.5K | |
| Stock-Based Compensation | $568.6K | $738.7K | $522.2K | $213.8K | $70.7K | |
| Change in Accounts Receivable | -$506.1K | -$8.3K | -$22.6K | -$36.3K | $1.3K | |
| Change in Inventories | -$3K | -$6.9K | -$7.3K | -$2K | $3.3K | |
| Cash From Operations | -$1.7M | -$2.1M | -$1.1M | -$260.6K | -$3.5M | |
| Capital Expenditures | $29K | $6.6K | -- | $49.7K | $14.6K | |
| Cash Acquisitions | -- | -$75.3K | -$8.5K | -- | -- | |
| Cash From Investing | -$309K | -$81.9K | -$8.5K | -$24.1K | -$14.7K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $714K | $225K | -- | |
| Long-Term Debt Repaid | -- | -- | -$170K | -$197.6K | -$1.1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$4M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $369.8K | $315K | $3.3M | $527.4K | $3.7M | |
| Beginning Cash (CF) | $10.1M | $5.7M | $90.1K | $232.4K | $741.4K | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.7M | -$1.8M | $2.1M | $242.7K | $99K | |
| Ending Cash (CF) | $8.4M | $3.8M | $2.2M | $475.1K | $840.4K | |
| Levered Free Cash Flow | -$1.8M | -$2.1M | -$1.1M | -$310.3K | -$3.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$9.4M | -$7M | -$10.7M | -$7.1M | -$24.9M | |
| Depreciation & Amoritzation | $34.6K | $229.9K | $23.9K | $408.8K | $927.1K | |
| Stock-Based Compensation | $1.6M | $2.9M | $2M | $1.1M | $1.4M | |
| Change in Accounts Receivable | -$524.1K | $469.1K | -$41K | -$77.2K | $3.3K | |
| Change in Inventories | -$106.1K | -$26.3K | $23.7K | $4.5K | $50K | |
| Cash From Operations | -$5.6M | -$6.4M | -$5.7M | -$3.9M | -$6.3M | |
| Capital Expenditures | $92.8K | $432.2K | $6.2K | $494.4K | $148.7K | |
| Cash Acquisitions | -$98.1K | -$1.8M | -$1.6K | -$2M | $472K | |
| Cash From Investing | -$471.1K | -$1.9M | -$7.8K | -$2.5M | $373.4K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $1.5M | $2.7M | $1.1M | |
| Long-Term Debt Repaid | -- | -- | -$170K | -$1.5M | -$1.8M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $14.2M | $3.7M | $4M | $4.7M | $6.3M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $8.1M | -$4.6M | -$1.7M | -$1.7M | $365.3K | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$5.7M | -$6.8M | -$5.7M | -$4.4M | -$6.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$2.5M | -$2.8M | -$2.6M | -$1.6M | -$17.4M | |
| Depreciation & Amoritzation | $8.7K | $72.5K | $19.1K | $227K | $234.5K | |
| Stock-Based Compensation | $568.6K | $738.7K | $522.2K | $213.8K | $70.7K | |
| Change in Accounts Receivable | -$506.1K | -$8.3K | -$22.6K | -$36.3K | $1.3K | |
| Change in Inventories | -$3K | -$6.9K | -$7.3K | -$2K | $3.3K | |
| Cash From Operations | -$1.7M | -$2.1M | -$1.1M | -$260.6K | -$3.5M | |
| Capital Expenditures | $29K | $6.6K | -- | $49.7K | $14.6K | |
| Cash Acquisitions | -- | -$75.3K | -$8.5K | -- | -- | |
| Cash From Investing | -$309K | -$81.9K | -$8.5K | -$24.1K | -$14.7K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $714K | $225K | -- | |
| Long-Term Debt Repaid | -- | -- | -$170K | -$197.6K | -$1.1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$4M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $369.8K | $315K | $3.3M | $527.4K | $3.7M | |
| Beginning Cash (CF) | $10.1M | $5.7M | $90.1K | $232.4K | $741.4K | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.7M | -$1.8M | $2.1M | $242.7K | $99K | |
| Ending Cash (CF) | $8.4M | $3.8M | $2.2M | $475.1K | $840.4K | |
| Levered Free Cash Flow | -$1.8M | -$2.1M | -$1.1M | -$310.3K | -$3.6M | |
Get IVF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IVF
Sector
P/E ratio
--
24.07x
PEG ratio
--
0.00x
P/B ratio
--
1.81x
Price / LTM sales
0.08x
1.67x
Growth Metrics
IVF
Sector
Revenue growth
3.86%
4.06%
Earnings growth
--
7.49%
Revenue (5-year growth)
34.57%
8.01%
Earnings forecast
--
-$0.20
Profitability
IVF
Sector
Profitability FY 2024
$2.9M
$47.5M
Return on invested capital
-313.33%
-16.26%
Return on assets
-94.64%
-13.27%
Return on equity
-714.24%
-18.61%
Earnings Date
Last Earnings Date
May
20
Next Earnings Date
Aug
14
Estimated Next Earnings Date
Aug
19
Balance Sheet
IVF
Sector
Total cash
$840.4K
$35.7M
Short term investments
--
$29.7M
Total assets
$46.4M
$106.9M
Long term debt
$6.5M
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
